Sentiment analysis revealed that 31.8% of discussions were negative, 50.1% were neutral, and 17.4% were positive
For example, recent publications suggest these drugs tone down overactive immune reactions in the brain, a process that could help treat neurodegenerative diseases such as Parkinsons and Alzheimers
SURMOUNT-3 (tirzepatide + intensive lifestyle intervention, 84 weeks): after a 12-week lifestyle lead-in, tirzepatide produced an additional 21.1% body-weight loss vs
Reported issues in practice may include headache, dizziness, nausea, flushing, or changes in sleep pattern (such as vivid dreams or temporary sleep disruption)
T., Bestwick, J., Steeds, R
J., Chandrasekharan, B